Sía eftir: Last updated date SelectEftirFyrirFrom - To Date Lokadagsetning This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorPRIMEParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Niðurstöður (3828) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 March 2022 11 mars 2022NewsHumanCOVID-19PharmacovigilanceReferralsVaccines PRIME enables earlier availability of life-changing medicines 3 mars 2022NewsHumanEarly access Regulation on EMA’s extended mandate becomes applicable 1 mars 2022NewsHumanCorporateGovernanceMedicine shortagesScientific adviceVaccines New medicine for rare type of eye cancer 25 febrúar 2022NewsHumanMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 February 2022 25 febrúar 2022NewsHumanCOVID-19Medicines EMA recommends authorisation of booster doses of Comirnaty from 12 years of age 24 febrúar 2022NewsHumanCOVID-19Vaccines EMA recommends approval of Spikevax for children aged 6 to 11 24 febrúar 2022NewsHumanCOVID-19Vaccines European medicines regulatory network adopts EU common standard for electronic product information 22 febrúar 2022NewsHumanProduct information Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 February 2022 21 febrúar 2022NewsVeterinaryMedicines Veterinary medicines: highlights of 2021 15 febrúar 2022NewsVeterinary 1 … 48 49 50 51 52 Page 52 of 383 53 54 55 56 … 383
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 March 2022 11 mars 2022NewsHumanCOVID-19PharmacovigilanceReferralsVaccines
Regulation on EMA’s extended mandate becomes applicable 1 mars 2022NewsHumanCorporateGovernanceMedicine shortagesScientific adviceVaccines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 February 2022 25 febrúar 2022NewsHumanCOVID-19Medicines
EMA recommends authorisation of booster doses of Comirnaty from 12 years of age 24 febrúar 2022NewsHumanCOVID-19Vaccines
EMA recommends approval of Spikevax for children aged 6 to 11 24 febrúar 2022NewsHumanCOVID-19Vaccines
European medicines regulatory network adopts EU common standard for electronic product information 22 febrúar 2022NewsHumanProduct information
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 February 2022 21 febrúar 2022NewsVeterinaryMedicines